Evidence map›Paper›PMID 31484394›Full record

ReviewBiomolecules2019

Microbial Pyrrolnitrin: Natural Metabolite with Immense Practical Utility.

Shraddha Pawar, Ambalal Chaudhari, Ratna Prabha, Renu Shukla, Dhananjaya P Singh

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 99 citations in OpenAlex.

  1. Role of anti-Applied and environmental microbiology · 2026
    Article
  2. Article
  3. Microbial Biofilms Dynamics and Functionality in an UrbanEnvironmental science & technology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Biological control ofFrontiers in microbiology · 2026
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. New Insights intoAntibiotics (Basel, Switzerland) · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shraddha PawarSchool of Life Sciences, Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon 425001, India. pawarshraddha1989@gmail.com.
Ambalal ChaudhariSchool of Life Sciences, Kavayitri Bahinabai Chaudhari North Maharashtra University, Jalgaon 425001, India. ambchasls@gmail.com.
Ratna PrabhaICAR-National Bureau of Agriculturally Important Microorganisms, Maunath Bhanjan 275101, India. ratnasinghbiotech30@gmail.com.
Renu ShuklaICAR-National Bureau of Agriculturally Important Microorganisms, Maunath Bhanjan 275101, India. renuiari@rediffmail.com.ORCID 0000-0002-1868-5832
Dhananjaya P SinghICAR-National Bureau of Agriculturally Important Microorganisms, Maunath Bhanjan 275101, India. Dhananjaya.Singh@icar.gov.in.
National Bureau of Agriculturally Important Microorganisms · INKavayitri Bahinabai Chaudhari North Maharashtra University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pyrrolnitrin (PRN) is a microbial pyrrole halometabolite of immense antimicrobial significance for agricultural, pharmaceutical and industrial implications. The compound and its derivatives have been isolated from rhizospheric fluorescent or non-fluorescent pseudomonads,

Indexed as

Antifungal AgentsBurkholderiaFermentationFungiMicrobial Sensitivity TestsPseudomonasPyrrolnitrinSerratiaAntifungal AgentsPyrrolnitrinantifungal activityapplicationsbiochemistrybiosynthesisHalometabolitespyrrolnitrinspectral properties

Identifiers

PMID31484394
PMCPMC6769897
OpenAlexW2971666690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.